Global HIV Diagnosis
Market Report
2024
The Global HIV Diagnostics Market size is USD 4158.2 million in 2024. The growing incidence of HIV is expected to boost sales to USD 8578.793165 Million by 2031 with a Compound Annual Growth Rate (CAGR) of 10.90% from 2024 to 2031.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of HIV Diagnosis Market Report 2024.
According to Cognitive Market Research, the global HIV Diagnostics market size is USD 4158.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 10.90% from 2024 to 2031.
Base Year | 2023 |
Historical Data Time Period | 2019-2023 |
Forecast Period | 2024-2031 |
Global Market Size | 121212 |
Country Market Size | 121212 |
North Americ Market Size | 121212 |
Europe Market Size | 121212 |
Asia Pacific Market Size | 121212 |
South America Market Size | 121212 |
Middle East and Africa Market Size | 121212 |
Market Drivers:
| |
Market Restrains:
| |
Market Trends:
|
Market Split by Product |
|
Market Split by Test Type |
|
Market Split by Mode |
|
Market Split by End User |
|
Market Split by Conclusion | |
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of HIV Diagnosis industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
HIV Diagnosis Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
HIV diagnostics encompass the diverse techniques and examinations employed to ascertain whether an individual's body harbors the Human Immunodeficiency Virus (HIV). These tests are essential for detecting HIV infection, which enables prompt medical attention and viral management. HIV antibodies in the blood or oral fluid can be found using the widely used initial screening test known as ELISA (Enzyme-Linked Immunosorbent Assay). Point-of-care diagnostics that are quick and can yield results in 20 to 30 minutes. They are helpful for quick findings but less sensitive than ELISA used in a lab. The market is being driven by several factors including the growing prevalence of sexually transmitted diseases, rising public and private initiatives, growing awareness and others.
Throughout the many decades of the HIV pandemic, the number of infected individuals is continually rising. The socioeconomic variables driving this continuous increase also suggest that preventative measures have not been successful. Even though many of these infections are preventable, there are an estimated 20 million new cases of STDs in the US each year, and the rate is still rising. Moreover, there are over 1.2 million HIV-positive individuals residing in the United States. Attempts to encourage testing and screening for sexually transmitted infections can ascertain an individual's likelihood of acquiring one and help those who already have one receive treatment, so enhancing their health and lowering the danger of HIV spreading to others. Approximately 38.4 million people worldwide were HIV positive in 2021. Among these, women and girls made up nearly 54%.
HIV is among the world's most important public health concerns. As a result, there is a global commitment to stopping new HIV infections and giving everyone on the planet access to HIV therapy. WHO recommends testing for HIV to anyone who might be at risk. The World Bank was a leader in global financing for HIV/AIDS in the early phases of the pandemic and has contributed US$4.6 billion to programs related to the illness since 1989. Because of assistance from the Bank—more precisely, through the International Development Association—for 1,500 counseling and testing centers, about 7 million people have had HIV tests.
A proper infrastructure for healthcare delivery is lacking in many areas, especially in poor nations, which makes it difficult to provide diagnostic services. This covers concerns with the supply chain, inadequate laboratory facilities, and skilled staff. It might be particularly difficult to access diagnostic services in rural and isolated places due to a lack of healthcare facilities and inadequate transportation infrastructure. Furthermore, HIV diagnosis rates are lower in the developing Asia-Pacific, Middle East, and African regions. These areas require a sufficient number of diagnostic facilities. Additionally, the diagnosis process needs to be explained to the majority of patients, which restricts market growth in these areas.
The COVID-19 pandemic has had a significant impact on the HIV diagnostics market, both in terms of challenges and opportunities. There was a decrease in HIV testing and diagnostic services during the pandemic as a result of the extensive healthcare resources being redirected to handle COVID-19. Some facilities were converted to provide COVID-19 treatment, and clinics and labs had a staffing crisis. Reduced HIV testing rates were the outcome of routine and community-based HIV testing programs being frequently halted to stop the spread of COVID-19. The adoption of telemedicine and remote healthcare services was expedited by the epidemic, nevertheless. While reducing the danger of COVID-19 transmission, online consultations and telehealth services enabled ongoing HIV care and counseling without interruption.
We have various report editions of HIV Diagnosis Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
The market for HIV diagnostics is anticipated to continue changing as a result of technological developments, rising consumer demand for quick and precise testing options, and initiatives to provide diagnostic access in underserved areas. In the highly competitive world of HIV diagnostics, sustainable growth and innovation will depend on stakeholder collaboration and regulatory change adaptability.
February 2023: Roche announced that it is extending its partnership with the U.S. Centers for Disease Control and Prevention (CDC) to improve laboratory capacities in nations that are heavily impacted by the TB and HIV epidemics. Roche and the CDC will work to improve HIV and tuberculosis prevention, detection, and treatment outcomes in a few countries in Africa, Eastern Europe, Central Asia, and the Western Hemisphere (e.g., Latin America, Central America, and Caribbean regions) through the implementation of a public-private partnership (PPP) called "Lab Networks for Health”. Source: https://diagnostics.roche.com/us/en/news-listing/2023/roche-joins-cdc-strengthen-labs-fight-against-hiv-tuberculosis.html.Top Companies Market Share in HIV Diagnosis Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue. North America's strong healthcare infrastructure and high healthcare spending translate into a sizable portion of the worldwide HIV diagnostics market. In addition, the market is propelled by ongoing technology developments, rising HIV/AIDS prevalence, and robust government programs for HIV treatment and prevention. Furthermore, the presence of major players in the region especially in the US is expected to drive the growth of the market.
Asia Pacific stands out as the fastest-growing region in the HIV Diagnostics market. The epidemiological profiles of the region vary, with certain countries facing concentrated epidemics among critical populations such as injectable drug users, sex workers, and men who have sex with men (MSM). Testing and treatment initiatives are also driven by national HIV/AIDS control programs and initiatives that are funded by international organizations such as UNAIDS and WHO. Furthermore, the increasing awareness among the population is another important factor driving the market expansion in the region.
The current report Scope analyzes HIV Diagnosis Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!
According to Cognitive Market Research, the global HIV Diagnostics market size was estimated at USD 4158.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 1663.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.1% from 2024 to 2031.
According to Cognitive Market Research, the global HIV Diagnostics market size was estimated at USD 4158.2 Million out of which Europe held the market of more than 30% of the global revenue with a market size of USD 1247.46 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.4% from 2024 to 2031.
According to Cognitive Market Research, the global HIV Diagnostics market size was estimated at USD 4158.2 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 956.39 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.9% from 2024 to 2031.
According to Cognitive Market Research, the global HIV Diagnostics market size was estimated at USD 4158.2 Million out of which Latin America market of more than 5% of the global revenue with a market size of USD 207.91 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.3% from 2024 to 2031.
According to Cognitive Market Research, the global HIV Diagnostics market size was estimated at USD 4158.2 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 83.16 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.6% from 2024 to 2031.
Global HIV Diagnosis Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing HIV Diagnosis Industry growth. HIV Diagnosis market has been segmented with the help of its Product, Test Type Mode, and others. HIV Diagnosis market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
According to Cognitive Market Research, Consumables stand out as the dominating category. Due to rising diagnostic service demand, technology developments, and growing healthcare infrastructure, the market for consumables is expected to grow at a strong rate. Crucial supplies for this market include fixatives, processing chemicals, embedding mediums, staining reagents, and mounting media. The industry is expected to grow significantly in several areas, especially emerging countries, because of the increased frequency of sexually transmitted diseases and the adoption of cutting-edge technologies.
Software & Services emerge as the fastest-growing category in the HIV Diagnostics market due to improvements in technology and growing public awareness of HIV and AIDS. This increase can also be attributed to numerous government initiatives aimed at raising awareness and lessening the stigma associated with these illnesses. For example, the Centers for Disease Control and Prevention's Let's Stop HIV Together (Together) campaign aims to decrease stigma around HIV, increase diagnostics and testing, and boost knowledge of the virus.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of HIV Diagnosis Industry. Request a Free Sample PDF!
According to Cognitive Market Research, the dominating category is Antibody Tests. Rapid testing and antibody-based assays, such as ELISA (Enzyme-Linked Immunosorbent Assay), are commonly utilized for HIV infection screening and early detection. They identify antibodies that are unique to HIV that the immune system produces in reaction to the infection. The accuracy of antibody tests has also been improved by ongoing advancements in assay sensitivity and specificity, which have decreased false positives and false negatives. The advent of fourth-generation tests that identify the p24 antigen in addition to HIV antibodies has increased early detection rates and fueled market expansion.
The fastest-growing category in the HIV Diagnostics market is CD4 Tests. In managing and treating HIV/AIDS, CD4 testing is essential, especially when it comes to tracking the disease's course and directing treatment choices. One important biomarker for evaluating the immunological health of people living with HIV is the CD4 T-cell count. Tracking CD4 levels aids in identifying the HIV infection stage, forecasts the course of the illness, and directs the start and continuation of antiretroviral medication (ART).
The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the HIV Diagnosis market report 2024 Edition by contacting our team.
Mode Segment Analysis
According to Cognitive Market Research, the dominating category is Lab based. Because their results are accurate. Advanced equipment is used by skilled personnel in diagnostic laboratories or healthcare facilities to perform lab-based testing. It provides precise results, permits extended monitoring, and is necessary for intricate analysis and confirmatory tests. Technologies enabling rapid and point-of-care testing also shorten the interval between testing and the initiation of treatment, allowing for early intervention. The market has tremendous potential to improve efficiency, accuracy, and accessibility, which will eventually benefit HIV patients and the worldwide effort to combat the illness.
The fastest-growing category in the HIV Diagnostics market is Self test. Because they are convenient and easy to use. Self-testing enables anyone to use a self-collection kit to conduct diagnostic tests at home and interpret the data on their own. It makes early detection easier and provides anonymity. Self-test kits are now more widely available, more accurate, and offer quicker turnaround times. People can now take charge of their health and overcome obstacles like stigma and inconvenience associated with traditional testing methods. HIV diagnosis is facilitated by self-testing and lab-based testing methods that accommodate varying requirements and preferences, raise awareness, and allow for efficient viral control.
End User Segment Analysis
According to Cognitive Market Research, the dominating category is Diagnostic Laboratories. Numerous HIV tests, such as antibody/antigen assays, nucleic acid tests (NATs), CD4 counts, and viral load testing, are available from diagnostic labs. These labs have state-of-the-art equipment that allows for high-throughput testing, guaranteeing speedy and accurate findings.
The fastest-growing category in the HIV Diagnostics market is Hospitals. The affordability and accessibility of hospital-based treatments can be impacted by the price of sophisticated diagnostic tests and the intricacy of payment regulations. Maintaining hospital diagnostic services requires acceptable reimbursement rules and sufficient resources.
Research Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses
I played a pivotal role in conducting market research and competitive analysis. I have a demonstrated ability to synthesize diverse data sources, identify trends, and translate findings into actionable recommendations. My collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization. I am committed to maintaining excellence through continuous learning and staying ahead of industry trends. Regular participation in conferences and professional development opportunities keeps my skills sharp and relevant.
Disclaimer:
Product | Consumables, Assays and Kits & Reagents, Other Consumables, Instruments, Software & Services |
Test Type | Antibody Tests, HIV-1 Screening Test, ELISA, Rapid Tests, Home Access Dried Blood Spot, HIV-1 Confirmatory Tests, Western Blot Tests, Indirect Immune Fluorescent Antibody Assays (IFA), Line Immunoassays (LIA), Radio-Immunoprecipitation Assays (RIPA), HIV-2 & Group O Diagnostic Tests, Viral Load Tests, CD4 Tests, Tests for Early Infant Diagnosis, Tests for Viral Identification |
Mode | Self test, Lab based |
End User | Diagnostic Laboratories, Hospitals, Blood Banks, Home Care Settings, Other End Users |
Conclusion | |
List of Competitors | Bristol-Myers Squibb Company, Abbott, Alere Inc., Gilead Sciences, Inc., Janssen Global Services, LLC, VIIV Healthcare, Merck & Co. Inc., BD, Beckman Coulter, Inc., Sysmex Europe SE, Apogee Flow Systems, Point Care, Zyomtronix, Inc., Hoffmann-La Roche Ltd., Mylan N.V. F., Siemens Healthcare GmbH, QIAGEN |
This chapter will help you gain GLOBAL Market Analysis of HIV Diagnosis. Further deep in this chapter, you will be able to review Global HIV Diagnosis Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
Chapter 2 North America Market Analysis
Purchase Add-Ons to Customize the Report Edition and get further granular data level data about the North America market. Add-On Cost: Request before placing the order, Respective Pricing will be informed after sending the inquiry
Qualitative Analysis for the North America Market: North America HIV Diagnosis Market Trends North America HIV Diagnosis Technological Road Map North America HIV Diagnosis Market Drivers North America HIV Diagnosis Market Restraints North America HIV Diagnosis Market Opportunity Market Attractiveness Analysis COVID – 19 Impact Analysis PESTEL Analysis Porter’s Five Forces Analysis Product Life Cycle Industrial Chain Analysis
You can purchase only the Executive Summary North America Market (2019 vs 2024 vs 2031)
Chapter 3 Europe Market Analysis
You can purchase only the Executive Summary Europe Market (2019 vs 2024 vs 2031)
Chapter 4 Asia-Pacific Market Analysis
You can purchase only the Executive Summary Asia Pacific Market (2019 vs 2024 vs 2031)
Chapter 5 South America Market Analysis
You can purchase only the Executive Summary South America Market (2019 vs 2024 vs 2031)
Chapter 6 Middle East and Africa Market Analysis
You can purchase only the Executive Summary Middle East and Africa Market (2019 vs 2024 vs 2031)
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Product Analysis 2019 -2031, will provide market size split by Product. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Product Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Test Type Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Mode Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by End User Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 14 Market Split by Conclusion Analysis 2019 -2031
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global HIV Diagnosis market
Chapter 15 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Why Consumables have a significant impact on HIV Diagnosis market? |
What are the key factors affecting the Consumables and Assays and Kits & Reagents of HIV Diagnosis Market? |
What is the CAGR/Growth Rate of Antibody Tests during the forecast period? |
By type, which segment accounted for largest share of the global HIV Diagnosis Market? |
Which region is expected to dominate the global HIV Diagnosis Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|
Published Report Editions
are Just a Tip of an Iceberg
Access the Complete Database of
HIV Diagnosis Market
Request Sample